Do We Know Whether Researchers and Reviewers are Estimating Risk and Benefit Accurately?

Accurate estimation of risk and benefit is integral to good clinical research planning, ethical review, and study implementation. Some commentators have argued that various actors in clinical research systems are prone to biased or arbitrary risk/benefit estimation. In this commentary, we suggest th...

Full description

Saved in:  
Bibliographic Details
Authors: Hey, Spencer Phillips (Author) ; Kimmelman, Jonathan (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell [2016]
In: Bioethics
Year: 2016, Volume: 30, Issue: 8, Pages: 609-617
IxTheo Classification:NCH Medical ethics
NCJ Ethics of science
Further subjects:B risk / benefit
B research ethics
B Forecasting
B Judgment
Online Access: Volltext (Verlag)
Volltext (doi)

MARC

LEADER 00000caa a22000002 4500
001 1727675541
003 DE-627
005 20210831161829.0
007 cr uuu---uuuuu
008 200824s2016 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12260  |2 doi 
035 |a (DE-627)1727675541 
035 |a (DE-599)KXP1727675541 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Hey, Spencer Phillips  |e VerfasserIn  |4 aut 
245 1 0 |a Do We Know Whether Researchers and Reviewers are Estimating Risk and Benefit Accurately? 
264 1 |c [2016] 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Accurate estimation of risk and benefit is integral to good clinical research planning, ethical review, and study implementation. Some commentators have argued that various actors in clinical research systems are prone to biased or arbitrary risk/benefit estimation. In this commentary, we suggest the evidence supporting such claims is very limited. Most prior work has imputed risk/benefit beliefs based on past behavior or goals, rather than directly measuring them. We describe an approach - forecast analysis - that would enable direct and effective measure of the quality of risk/benefit estimation. We then consider some objections and limitations to the forecasting approach. 
650 4 |a Forecasting 
650 4 |a Judgment 
650 4 |a research ethics 
650 4 |a risk/benefit 
652 |a NCH:NCJ 
700 1 |a Kimmelman, Jonathan  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 30(2016), 8, Seite 609-617  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:30  |g year:2016  |g number:8  |g pages:609-617 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12260  |x Verlag 
856 |u https://doi.org/10.1111/bioe.12260  |x doi  |3 Volltext 
936 u w |d 30  |j 2016  |e 8  |h 609-617 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 374233834X 
LOK |0 003 DE-627 
LOK |0 004 1727675541 
LOK |0 005 20210831161829 
LOK |0 008 200824||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo 
LOK |0 936ln  |0 1550736558  |a NCH 
LOK |0 936ln  |0 1550736582  |a NCJ 
ORI |a SA-MARC-ixtheoa001.raw